Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2026)

Collegium Pharmaceutical has reported Convertible Debt over the past 6 years, most recently at $238.2 million for Q4 2025.

  • For Q4 2025, Convertible Debt changed 0.44% year-over-year to $238.2 million; the TTM value through Dec 2025 reached $238.2 million, changed 0.44%, while the annual FY2025 figure was $238.2 million, 0.44% changed from the prior year.
  • Convertible Debt for Q4 2025 was $238.2 million at Collegium Pharmaceutical, roughly flat from $238.0 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $262.4 million in Q1 2024 and troughed at $26.4 million in Q1 2022.
  • A 5-year average of $198.9 million and a median of $237.0 million in 2024 define the central range for Convertible Debt.
  • Biggest five-year swings in Convertible Debt: tumbled 81.08% in 2022 and later soared 891.35% in 2023.
  • Year by year, Convertible Debt stood at $140.0 million in 2021, then increased by 0.65% to $140.9 million in 2022, then surged by 86.07% to $262.1 million in 2023, then fell by 9.52% to $237.2 million in 2024, then increased by 0.44% to $238.2 million in 2025.
  • Business Quant data shows Convertible Debt for COLL at $238.2 million in Q4 2025, $238.0 million in Q3 2025, and $237.7 million in Q2 2025.